Immuneering Corporation

NASDAQ: IMRX · Real-Time Price · USD
3.79
0.75 (24.67%)
At close: Aug 15, 2025, 3:59 PM
3.65
-3.57%
After-hours: Aug 15, 2025, 07:49 PM EDT

Immuneering Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a -94.42M n/a 94.42M n/a 456.00 38.38K 94.42K 183.7K 189.59K 482.13K 660.04K 748.2K
Cost of Revenue
n/a n/a n/a n/a n/a 185.22K 195.78K 193.51K 189.63K 157.96M 19.34K 47.93K 90.85K 206.22K 219K 319K 409.16K
Gross Profit
n/a n/a n/a n/a n/a -94.6M -195.78K 94.23M -189.63K -157.96M 19.04K 46.49K 92.85K -16.63K 263.13K 341.04K 339.04K
Operating Income
-15.48M -18.56M -15.27M -14.91M -15.33M -16.3M -13.93M -13.5M -14.68M -13.99M -13.19M -11.65M -12.93M -11.12M -8.54M -7.99M -6.24M
Interest Income
438.52K 415.24K 547.07K 826.1K 804.88K 754.14K 855.53K 1.17M 831.27K 516.17K 222.99K 142.8K 132.51K 142.88K 17.4K 3.26K 6.36K
Pretax Income
-15.05M -18.05M -14.6M -14.08M -14.31M -15.08M -12.6M -12.19M -13.6M -13.25M -12.84M -11.53M -12.9M -11.09M -8.53M -7.99M -6.23M
Net Income
-15.05M -18.05M -14.6M -14.08M -14.31M -15.08M -12.6M -12.19M 1.06B -12.51M -12.5M -11.53M -12.87M -10.78M -8.53M -7.99M -6.23M
Selling & General & Admin
4.01M 3.69M 4.01M 4.25M 4.12M 4.38M 3.87M 4.04M 4.46M 4.11M 3.84M 3.7M 3.95M 3.15M 2.6M 1.34M 1.18M
Research & Development
11.47M 14.86M 11.25M 10.65M 11.2M 11.91M 10.05M 9.45M 10.21M 9.87M 9.36M 7.98M 9.06M 7.95M 6.21M 6.99M 5.39M
Other Expenses
7.32K 7.32K 7.32K 7.32K 7.32K 464.35K 7.32K 150.19K 7.32K 7.32K 7.32K -24.05K 8.1K n/a -8.09K n/a n/a
Operating Expenses
15.48M 18.56M 15.27M 14.91M 15.33M 16.3M 13.93M 13.51M 14.68M 13.99M 13.21M 11.69M 13.02M 11.1M 8.81M 8.33M 6.58M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
15.48M 18.56M 15.27M 14.91M 15.33M 16.3M 13.93M 13.51M 14.68M 13.99M 13.23M 11.74M 13.11M 11.31M 9.03M 8.65M 6.98M
Income Tax Expense
n/a n/a n/a n/a n/a -754.66K n/a -1.14M -1.08B -740.06K -343.79K -52.39K -29.42K -307.49K -17.46K 796.00 n/a
Shares Outstanding (Basic)
35.53M 31.05M 29.84M 29.65M 29.37M 29.27M 29.27M 28.65M 26.44M 26.41M 26.39M 26.39M 26.36M 25.98M 18.29M 23.89M 13.51M
Shares Outstanding (Diluted)
35.53M 31.05M 29.84M 29.65M 29.37M 29.27M 29.27M 28.65M 26.44M 26.41M 26.39M 26.39M 26.36M 25.98M 18.29M 23.89M 13.51M
EPS (Basic)
-0.42 -0.58 -0.49 -0.47 -0.49 -0.52 -0.43 -0.43 40.16 -0.47 -0.47 -0.44 -0.49 -0.42 -0.47 -0.33 -0.46
EPS (Diluted)
-0.42 -0.58 -0.49 -0.47 -0.49 -0.52 -0.43 -0.43 40.16 -0.47 -0.47 -0.44 -0.49 -0.42 -0.47 -0.33 -0.46
EBITDA
-15.39M -18.46M -15.18M -14.82M -15.23M -14.9M -13.84M -13.42M -14.6M -13.9M -13.11M -11.58M -12.7M -11.04M -8.5M -7.95M -6.2M
EBIT
-15.48M -18.56M -15.27M -14.91M -15.33M -16.3M -13.93M -13.5M -14.6M -13.99M -13.19M -11.65M -12.93M -11.12M -8.54M -7.99M -6.24M
Depreciation & Amortization
92.58K 93.43K 96.27K 97.85K 97.53K 185.22K 195.78K 193.51K 189.63K 189.28K 204.53K 202.36K 200.63K 52.5K 37.57K 35.11K 33.89K